These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30245898)

  • 21. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
    Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
    Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple organ failure and granulomatous hepatitis following intravesical bacillus Calmette-Guérin instillation.
    Desmet M; Moubax K; Haerens M
    Acta Clin Belg; 2012; 67(5):367-9. PubMed ID: 23189546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature.
    Oladiran O; Nwosu I; Oladunjoye A; Oladunjoye O
    J Community Hosp Intern Med Perspect; 2020 May; 10(2):168-170. PubMed ID: 32850058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disseminated pulmonary granulomas after intravesical bacillus Calmette-Guérin immunotherapy.
    De Diego A; Rogado MC; Prieto M; Nauffal D; Perpiñá M
    Respiration; 1997; 64(4):304-6. PubMed ID: 9257368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Guérin immunotherapy.
    Poletajew S; Krajewski W; Adamowicz J; Radziszewski P
    Anticancer Drugs; 2019 Jun; 30(5):517-522. PubMed ID: 30870228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated Bacillus Calmette-Guerin infections after intravesical therapy.
    Gerogianni I; Gravas S; Gourgoulianis K; Neonakis I; Petinaki E
    Indian J Med Microbiol; 2014; 32(4):438-9. PubMed ID: 25297033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulomas of the penis: a rare complication of intravesical therapy with Bacillus Calmette-Guerin.
    Lestre SI; Gameiro CD; João A; Lopes MJ
    An Bras Dermatol; 2011; 86(4):759-62. PubMed ID: 21987145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1986 Oct; 136(4):820-4. PubMed ID: 3761438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the Feasibility of Replacing Standard-Dose Bacillus Calmette-Guérin Immunotherapy with Other Intravesical Instillation Therapies in Bladder Cancer Patients: A Network Meta-Analysis.
    Wu C; Zhou X; Miao C; Zhang J; Tang Q; Chang X; Ni H
    Cell Physiol Biochem; 2017; 41(4):1298-1312. PubMed ID: 28278504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.
    Koga H; Kuroda M; Kudo S; Yamaguchi A; Usami M; Suzuki T; Naito S
    Int J Urol; 2005 Feb; 12(2):145-51. PubMed ID: 15733108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.
    Bisiaux A; Thiounn N; Timsit MO; Eladaoui A; Chang HH; Mapes J; Mogenet A; Bresson JL; Prié D; Béchet S; Baron C; Sadorge C; Thomas S; Albert EB; Albert PS; Albert ML
    J Urol; 2009 Apr; 181(4):1571-80. PubMed ID: 19230924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The possible influence of antibiotics on results of bacillus Calmette-Guérin intravesical therapy for superficial bladder cancer.
    van der Meijden PM; van Klingeren B; Steerenberg PA; de Boer LC; de Jong WH; Debruyne FM
    J Urol; 1991 Aug; 146(2):444-6. PubMed ID: 1856950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
    Yokomizo A; Kanimoto Y; Okamura T; Ozono S; Koga H; Iwamura M; Tanaka H; Takahashi S; Tsushima T; Kanayama HO; Akaza H; Shinohara N; Mugiya S; Nomata K; Nakamura T; Naito S
    J Urol; 2016 Jan; 195(1):41-6. PubMed ID: 26307162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.
    Kelley DR; Ratliff TL; Catalona WJ; Shapiro A; Lage JM; Bauer WC; Haaff EO; Dresner SM
    J Urol; 1985 Jul; 134(1):48-53. PubMed ID: 3892051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Hepatitis and Pneumonitis Caused by Disseminated Bacillus Calmette-Guérin Infection.
    Dibs K; Shehadeh I; Abu Atta O
    ACG Case Rep J; 2016 Jan; 3(2):130-2. PubMed ID: 26958569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse granulomatous mesenteric disease caused by intravesical bacillus Calmette-Guérin instillation masquerading as peritoneal carcinomatosis.
    Shapiro A; Vakar F; Kamat AM
    Urol Oncol; 2005; 23(5):352-3. PubMed ID: 16144670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N
    J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.